Table of Contents
<< Previous Issue | Jan 2021 (Vol: 2021, Issue: 1) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Sanofi Bolsters Immunology Portfolio with US$1.45 B Kymab Acquisition
- Section: Research & Development
-
Merck Forms NASH Therapy Alliance with Aligos to Bolster Liver Disease Pipeline
-
Genentech Partners with Ribometrix in US$1 B RNA Therapeutics Deal
-
Loxo Partners with Merus on Bispecific Antibody Therapies